Many of these codes are placeholders and aren't currently effective until an authorized product is specifically assigned. CMS and the AMA developed this code structure to make claims processing for administration of COVID-19 vaccines and monoclonal antibody infusions that get FDA EUA or FDA approval more efficient. Together, these codes describe the administration of the COVID-19 vaccines and the monoclonal antibody products, as they become available.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |